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Abstract
Alcoholic liver disease (ALD) is a major public health problem worldwide and is the leading cause 
of end-stage liver disease. While the ultimate control of ALD will require the prevention of 
alcohol abuse, better understanding of the mechanisms of alcohol-induced liver injury may lead to 
treatments of fatty liver, alcoholic hepatitis, and prevention or delay of occurrence of cirrhosis. 
The elucidation and the discovery of several new concepts in ALD pathogenesis have raised our 
understanding on the complex mechanisms and the potential in developing the new strategies for 
therapeutic benefits. In this review, we provide the most up-to-date information on the basic 
molecular mechanisms focusing on the role of fat-specific protein 27/CIDEC in the pathogenesis 
of ALD.
INTRODUCTION
Alcoholic liver disease (ALD) represents a spectrum of liver disorders with clinical and 
pathological changes in individuals after chronic excessive alcohol consumption.12 Patients 
may have minimal abnormalities from steatosis or may develop more severe signs and 
symptoms of liver disease seen in alcoholic hepatitis (AH) or cirrhosis.23 While the ultimate 
control of ALD will require the prevention of alcohol abuse, better understanding of the 
mechanisms/pathogenesis may lead to treatments of ALD.
Fatty liver, the accumulation of triglyceride droplets in the liver, is the most common and 
earliest response of the liver to excessive alcohol use.4 Synthesis of fatty acids and 
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triglyceride in excess of the capacity to oxidize it or export it in very low-density lipoprotein 
particles results in hepatic steatosis.56 The effect of ethanol was initially attributed to the 
changes in the redox state, generated from alcohol metabolism by alcohol and aldehyde 
dehydrogenase; however, recent evidence suggested a complex molecular regulation of 
ALD. Its pathogenesis involves the dysregulation of transcription factors and metabolic 
regulators, protein adduct formation, activation of inflammatory cytokines and Kupffer cells, 
elevation of lipopolysaccharide, and endoplasmic reticulum (ER) stress response (see review 
by Gao and Bataller2). In this report, we will focus on an emerging new mechanism on the 
role of fat-specific protein 27 (FSP27)/cell death-inducing DFF45-like effector C (CIDEC) 
in the pathogenesis of ALD.
FSP27/CIDEC
The mouse Fsp27 gene is the human homolog of CIDEC, belonging to the CIDE family of 
proteins. Three CIDEs have been reported in mouse (Cidea, Cideb, and FSP27/Cidec) and 
human (CIDEA, CIDEB, and CIDEC).78 FSP27/CIDEC proteins play an important role in 
the development of metabolic disorders as well as regulation of cell apoptosis.79–11 The 
Fsp27 gene has two isoforms, Fsp27α and Fsp27β.12 Fsp27α is highly expressed in white 
adipose tissues, the major organ for triacylglycerol (TAG) storage, whereas Fsp27β is highly 
expressed in brown adipose tissue and fatty liver.12 FSP27/CIDEC is a lipid droplet (LD) 
protein that plays an important role in droplet formation.13
LDs, intracellular organelles, are composed of a core of neutral lipids (TAG) covered by a 
monolayer of phospholipids, free cholesterol and specific proteins.1415 The ability to store 
neutral lipids in the form of LDs is evolutionarily conserved across species.14 LDs in the 
adipose tissues serve as the reservoirs for fatty acids (in the form of TAG), which can be 
released during starvation1416 and can be used for energetic substrates to high-demand 
tissues such as liver and muscle.17 There are several proteins, in addition to FSP27/CIDEC, 
which are involved in LD formation, notably the PAT (perilipin, adipophilin, and the tail-
interacting protein of 47 kDa) family proteins, perilipin (PLIN 1–5).141819
In the adipose tissues, FSP27/CIDEC stimulates formation of TAG droplets and inhibits β-
oxidation of non-esterified fatty acids.13 It is significantly upregulated101620–2223 and is 
important for expansion of LD size during adipogenesis.13 Recent studies found that FSP27/
CIDEC plays an important role in lipolysis through its interaction with adipose tissue 
triglyceride lipase (ATGL) and regulates insulin sensitivity in human adipocytes.1718 FSP27/
CIDEC facilitates the inhibitory effect of early growth response protein 1 (Erg1) on the 
transcription of ATGL,18 leading to reduced lipolysis, and enhancing lipid storage capacity 
in the adipocytes.17 The optimal fat storage is important in maintaining the overall metabolic 
phenotypes in the adipose tissues.1724 High levels of free fatty acid can inhibit protein kinase 
B (AKT) phosphorylation and impair insulin sensitivity.25 It is interesting that insulin-
stimulated AKT activation is inhibited by siRNA-mediated FSP27 silencing. Using the gain 
of function approach, FSP27 overexpression protects the adipocytes from free fatty acid 
(FFA)-induced insulin resistance. These data suggest that FSP27 might protect adipocytes 
from the deleterious effects of FFAs via suppression of ATGL-mediated lipolysis.17
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In mouse liver, Fsp27 expression is significantly induced during early fasting and in the 
presence of hepatic steatosis.92627 Knockdown of Fsp27 ameliorates hepatic steatosis,9 
while overexpression of Fsp27 induces the accumulation of LDs and TAG contents.16 The 
regulation of hepatic Fsp27 expression is complex. Fasting-induced Fsp27 expression was 
completely obliterated in cyclic AMP-responsive element binding protein H (CREBH) 
knockout mice.12 Interestingly, the expression of other LD proteins in the PAT family was 
largely unaffected by the loss of CREBH,12 suggesting the role of CREBH in regulating 
Fsp27 expression. Overexpression of the constitutively active CREBH strongly induced 
Fsp27β in mouse hepatocytes and promoted LD enlargement and TAG accumulation in the 
liver, while the loss of CREBH decreased hepatic Fsp27β expression in fasted mice.12
In summary, FSP27/CIDEC, a lipid protein, plays an important role in lipolysis, insulin 
sensitivity, and TAG accumulation in steatotic liver.
Animal models for ALD
Currently, the most widely used model for alcohol-induced liver injury is ad libitum feeding 
with the Lieber-DeCarli liquid diet containing ethanol for 4–6 weeks;28 however, this model, 
without additional secondary insult, only induces mild steatosis, slight elevation of serum 
alanine transaminase (ALT) and little or no inflammation.28 It is not an ideal mouse model 
to study the mechanism of ALD beyond the hepatic steatosis stage.
AH, a severe form of ALD, can occur in patients with ALD, especially in those with recent 
excessive alcohol consumption.23 In addition to the presence of steatosis, the typical 
findings of AH demonstrate neutrophilic infiltration, hepatocyte ballooning, and hyaline 
inclusions.23 Slow progress in the field of ALD has resulted partly from a lack of 
experimental models of advanced ALD and AH. A model of short-term (10-day) plus binge 
ethanol feeding in mice (the National Institute on Alcohol Abuse and Alcoholism (NIAAA) 
model) was developed, which showed significant elevations of transaminases (AST and 
ALT), mild steatosis, and neutrophil infiltration, yet no fibrosis.28 When chronic ethanol 
feeding is extended to a period to 8 weeks, followed by gavage administration of single or 
multiple doses of ethanol, mice developed the phenotypic features of severe alcoholic 
steatohepatitis (ASH) and mild fibrosis.7 Alteration in gene expression profiles, determined 
by microarray analyses, in this model was found to be similar to those in human AH, 
suggesting that this is a very useful model to study the mechanism of AH.7
FSP27/CIDEC promotes development of ASH in mice
Among the most highly upregulated genes based on the array data, the Fsp27 gene was 13-
fold upregulated in mice chronically fed with ethanol for 8 weeks followed by 1 binge (E8W
+1B).7 The array data were confirmed by realtime PCR (RT-PCR) analysis of the liver 
tissues which showed that hepatic expression of Fsp27 was upregulated by 10-fold in mice 
after E8w+1B feeding.7
The gene as well as protein expression of both isoforms of Fsp27 gene were highly 
upregulated in mice fed with E8w+1B, when compared with controls.7 However, it is 
important to note that ethanol does not directly upregulate hepatic FSP27 protein expression, 
as the expression of this protein was not observed when primary hepatocytes were treated 
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with ethanol (100 mM) in vitro.7 Further studies suggest that the upregulation of Fsp27 is, in 
fact, secondary to the activation of ER by ethanol.7
The role of Fsp27 in the pathogenesis of AH was also examined by using the ‘loss of 
function’ approach with Ad-Fsp27 short hairpin RNA (shRNA) and hepatocyte-specific 
Fsp27 deletion (Fsp27Hep−/−). Interestingly, the levels of serum transaminases (aspartate 
aminotransferase (AST) and ALT), hepatic steatosis, and degree of hepatic apoptosis (as 
measured by the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) 
assay) were reduced in Ad-Fsp27 shRNA-treated mice as well in Fsp27Hep−/− mice 
compared with those in pair-fed controls.7 Further, the hepatic levels of malondialdehyde 
and 4-hydroxynonenal (oxidative stress/lipid peroxidation markers), which were highly 
elevated in E8w+1B mice, were significantly reduced after treatment with Ad-Fsp27 
shRNA, suggesting that FSP27 promotes ethanol-induced hepatic oxidative injury.7
FSP27 protein is found in the cytoplasm of adipocytes. Recent studies demonstrated that 
FSP27 protein is present in the cytoplasm and mitochondria from steatotic hepatocytes from 
ethanol-fed mice.7 Overexpression of FSP27 protein via the injection of Ad-FSP27 
exacerbated the elevation of serum ALT and AST levels and decreased mitochondrial 
contents and mitochondrial complex I activity in E8W+1B treated mice.7 The combination 
of FSP27 overexpression and ethanol exposure synergistically increased mitochondrial 
reactive oxygen species (ROS) generation in hepatocytes in vitro.7 Finally, FSP27 
overexpression also induces hepatocyte death in the presence of ethanol by induction of Bax 
translocation and cytochrome C release, the two important early events in apoptotic 
pathway.7
Role of FSP27/CIDEC in human ASH
Recent evidence also suggests an important role for FSP27 in the pathogenesis of human 
ASH. First, microarray data revealed that CIDEC, the human homolog of Fsp27, was 
upregulated by fivefold in human liver samples from patients with AH compared with 
healthy controls.7 RT-PCR analyses demonstrated that the expression of CIDEC mRNA was 
more than 40-fold increase in these samples. Second, the upregulation of hepatic CIDEC 
was closely associated with the severity of hepatic steatosis as well as the prognostic models 
for AH such as model for end-stage liver disease and age, serum bilirubin, international 
normalized ratio, and serum creatinine (ABIC) scores.7 It is also positively correlated with 
hepatic venous pressure gradient and is an independent predictor for 90-day mortality in 
patients with AH.7 The schematic diagram on the mechanism of FSP27/CIDEC and ASH is 
shown in figure 1.
FSP27/CIDEC contributes to the synergistic effect of obesity and acute ethanol-induced 
ASH
Obesity and alcohol consumption often coexist and synergistically promote the development 
and progression of liver injury, fibrosis, and hepatocellular carcinoma in patients.2930 The 
studies from several animal models also revealed that alcohol feeding and high-fat diet 
(HFD) feeding synergistically promote steatohepatitis in rodents.31 Interestingly, a simple 
model of mixed steatohepatitis by feeding mice an HFD followed by gavage with a single 
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dose of ethanol was recently developed.32 The most striking finding from this model was 
that feeding mice an HFD for as little as 3 days, which has been shown to impair hepatic 
insulin sensitivity,33 significantly aggravated the acute ethanol binge-induced neutrophilia, 
hepatic neutrophil infiltration, and liver injury.32 Long-term (3 months) HFD feeding plus 
gavage of a single dose of ethanol caused severe steatohepatitis with severe steatosis, 
massive neutrophil infiltration, and marked elevation of serum ALT and AST. Mechanistic 
studies revealed that hepatic expression of chemokine (C-X-C motif) ligand 1 (CXCL1) was 
highly upregulated (up to 20-fold and 30-fold) in the liver after 3-day HFD+ethanol and 3-
month HFD+ethanol feeding, respectively.32 Genetic deletion of the Cxcl1 or blocking 
CXCL1 with a neutralizing antibody ameliorated HFD+acute ethanol-induced liver 
inflammation and injury. In addition, it is known that hepatic Fsp27 mRNA is highly 
elevated after HFD feeding34 and that overexpression of FSP27 increases the sensitivity of 
hepatocytes to ethanol-induced ROS production and injury.7 Thus, it is plausible to speculate 
that upregulated hepatic FSP27 expression is another important mechanism by which HFD-
fed mice are very sensitive to acute alcohol-induced acute ASH.
CONCLUSION
The use of chronic ethanol feeding for 8 weeks followed by gavage administration of a 
single dose of ethanol can induce hepatic histology mimicking ASH. This model, therefore, 
will be useful for the future study to identify and investigate other important mediators that 
may contribute to the pathogenesis of ASH. Using this mouse model, the researchers have 
found the important role of hepatic FSP27/CIDEC in promoting ASH in mice as well as in 
patients with ASH. However, further studies investigating the role of FSP27/CIDEC notably 
in the adipose tissues and the cross talk between adipose tissue and liver on the pathogenesis 
of hepatic steatosis and ASH in mouse model of obesity and alcohol feeding will be needed.
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Figure 1. 
Schematic diagram on the potential role of FSP27/CIDEC in the pathogenesis of AH 
(modified from Xu et al7). AH, alcoholic hepatitis; CIDEC, cell death-inducing DFF45-like 
effector C; ER, endoplasmic reticulum; FSP27, fat-specific protein 27; ROS, reactive oxygen 
species.
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